Skip to main content
NewslettersWatchlist

Hims & Hers Health Inc(HIMS-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low21.36
Day High24.58
Open:21.90
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Motley Fool
Amazon Sets Sights on Both Hims & Hers and Temu. Is This a Golden Opportunity to Buy the Stock?
Motley Fool
Hims & Hers Stock Is Down 30% This Week: Here's What Happened
Motley Fool
Should You Buy Hims & Hers Stock on the Dip?
Barchart
Stocks Close Lower on Hawkish Powell
Baystreet
Another Peak for TSX
Motley Fool
Up 298% in a Year, Is Hims & Hers Health Still a Buy?
MarketBeat
3 Top Stocks Crushing Q3 Earnings With Strong 2024 Guidance
Motley Fool
After Another Blowout Quarter of Surging Revenue, Is Hims & Hers Stock a Once-in-a-Decade Buy?
Motley Fool
Missed Out on Eli Lilly? Buy This Amazing Growth Stock Instead
MarketBeat
Hims & Hers: Why This Healthcare Stock’s Growth Makes It a Buy
Motley Fool
Could This Magnificent Pharma Stock 10x in the Next 5 Years?
MarketBeat
Top 3 Stocks Institutions Are Buying Right Now
Stock Target Advisor
Hims & Hers Health Inc (HIMS) Surges 275%: Stock Analysis and Future Outlook
Motley Fool
Hims & Hers Stock Dropped: Here's What You Need to Know
Motley Fool
Why Hims & Hers' Incredible Growth Will Continue
Motley Fool
Where Does Hims & Hers Stock Go From Here?
Motley Fool
2 Incredibly Cheap Growth Stocks to Buy Right Now
Motley Fool
2 No-Brainer Growth Stocks to Buy With $500 Right Now
Motley Fool
What Is Going On With Hims & Hers Stock?
MarketBeat
Top 3 Stocks with Explosive Call Option Activity: What to Watch
MarketBeat
Hims & Hers Stock Joins S&P 600: Is More Upside on the Horizon?
Motley Fool
With Its GLP-1 Drugs No Longer in a Shortage, Is Now the Time to Buy Eli Lilly Stock?

Profile

Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.